Hester Biosciences Ltd. | Small-cap | Healthcare
₹1,846.00
1.36%
| Hester Biosciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.1B
Gross Profit 2.2B 71.61%
Operating Income 442.5M 14.22%
Net Income 288.3M 9.27%
EPS (Diluted) ₹33.89

Balance Sheet Metrics

Total Assets 6.5B
Total Liabilities 3.3B
Shareholders Equity 3.3B
Debt to Equity 1.00

Cash Flow Metrics

Operating Cash Flow 554.9M
Free Cash Flow 439.2M

Revenue & Profitability Trend

Hester Biosciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.1B 3.0B 2.7B 2.4B 2.1B
Cost of Goods Sold 883.2M 1.1B 858.2M 725.4M 589.8M
Gross Profit 2.2B 1.9B 1.8B 1.6B 1.6B
Operating Expenses 993.0M 735.3M 714.9M 535.2M 450.8M
Operating Income 442.5M 422.8M 415.6M 564.7M 587.6M
Pre-tax Income 395.7M 319.5M 401.5M 535.0M 501.0M
Income Tax 107.4M 107.9M 121.2M 140.2M 154.0M
Net Income 288.3M 211.7M 280.4M 394.8M 347.0M
EPS (Diluted) ₹33.89 ₹22.20 ₹31.30 ₹46.22 ₹40.47

Income Statement Trend

Hester Biosciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.0B 2.1B 2.3B 1.9B 1.6B
Non-Current Assets 4.6B 4.5B 4.4B 3.7B 2.5B
Total Assets 6.5B 6.6B 6.7B 5.6B 4.1B
Liabilities
Current Liabilities 1.3B 1.1B 1.5B 969.0M 613.7M
Non-Current Liabilities 2.0B 2.5B 2.3B 2.0B 1.1B
Total Liabilities 3.3B 3.6B 3.8B 2.9B 1.8B
Equity
Total Shareholders Equity 3.3B 3.0B 2.9B 2.7B 2.4B

Balance Sheet Composition

Hester Biosciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 395.7M 319.5M 401.5M 535.0M 501.0M
Operating Cash Flow 554.9M 493.6M 19.7M 164.0M 477.3M
Investing Activities
Capital Expenditures 2.7M 550.0K 250.0K 1.8M 420.0K
Investing Cash Flow 7.6M 550.0K 250.0K -206.4M 11.2M
Financing Activities
Dividends Paid -51.7M -68.0M -85.1M -85.1M -56.2M
Financing Cash Flow -382.8M -108.0M 544.1M 1.1B -122.3M
Free Cash Flow 439.2M 237.4M -541.7M -870.0M 173.1M

Cash Flow Trend

Hester Biosciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 52.85
Price to Book 4.05
Price to Sales 4.84
PEG Ratio 1.00

Profitability Ratios

Profit Margin 8.73%
Operating Margin 10.74%
Return on Equity 9.16%
Return on Assets 4.58%

Financial Health

Current Ratio 1.56
Debt to Equity 65.28
Beta 0.15

Per Share Data

EPS (TTM) ₹33.95
Book Value per Share ₹443.02
Revenue per Share ₹388.40

Financial data is updated regularly. All figures are in the company's reporting currency.